Exon skipping induces uniform dystrophin rescue with dose-dependent restoration of serum miRNA biomarkers and muscle biophysical properties

<p>Therapies that restore dystrophin expression are presumed to correct Duchenne muscular dystrophy (DMD), with antisense-mediated exon skipping being the leading approach. Here we aimed to determine whether exon skipping using a peptide-phosphorodiamidate morpholino oligonucleotide (PPMO) con...

Full description

Bibliographic Details
Main Authors: Chwalenia, K, Oieni, J, Zemła, J, Lekka, M, Ahlskog, N, Coenen-Stass, AML, McClorey, G, Wood, MJA, Lomonosova, Y, Roberts, TC
Format: Journal article
Language:English
Published: Cell Press 2022
_version_ 1797111335496974336
author Chwalenia, K
Oieni, J
Zemła, J
Lekka, M
Ahlskog, N
Coenen-Stass, AML
McClorey, G
Wood, MJA
Lomonosova, Y
Roberts, TC
author_facet Chwalenia, K
Oieni, J
Zemła, J
Lekka, M
Ahlskog, N
Coenen-Stass, AML
McClorey, G
Wood, MJA
Lomonosova, Y
Roberts, TC
author_sort Chwalenia, K
collection OXFORD
description <p>Therapies that restore dystrophin expression are presumed to correct Duchenne muscular dystrophy (DMD), with antisense-mediated exon skipping being the leading approach. Here we aimed to determine whether exon skipping using a peptide-phosphorodiamidate morpholino oligonucleotide (PPMO) conjugate results in dose-dependent restoration of uniform dystrophin localization, together with correction of putative DMD serum and muscle biomarkers. Dystrophin-deficient&nbsp;<em>mdx</em>&nbsp;mice were treated with a PPMO (Pip9b2-PMO) designed to induce&nbsp;<em>Dmd</em>&nbsp;exon 23 skipping at single, ascending intravenous doses (3, 6, or 12&nbsp;mg/kg) and sacrificed 2&nbsp;weeks later. Dose-dependent exon skipping and dystrophin protein restoration were observed, with dystrophin uniformly distributed at the sarcolemma of corrected myofibers at all doses. Serum microRNA biomarkers (i.e., miR-1a-3p, miR-133a-3p, miR-206-3p, miR-483-3p) and creatinine kinase levels were restored toward wild-type levels after treatment in a dose-dependent manner. All biomarkers were strongly anti-correlated with both exon skipping level and dystrophin expression. Dystrophin rescue was also strongly positively correlated with muscle stiffness (i.e., Young&rsquo;s modulus) as determined by atomic force microscopy (AFM) nanoindentation assay. These data demonstrate that PPMO-mediated exon skipping generates myofibers with uniform dystrophin expression and that both serum microRNA biomarkers and muscle AFM have potential utility as pharmacodynamic biomarkers of dystrophin restoration therapy in DMD.</p>
first_indexed 2024-03-07T08:07:20Z
format Journal article
id oxford-uuid:ef05285d-bc6a-4f34-9683-5b01ad5d9b37
institution University of Oxford
language English
last_indexed 2024-03-07T08:07:20Z
publishDate 2022
publisher Cell Press
record_format dspace
spelling oxford-uuid:ef05285d-bc6a-4f34-9683-5b01ad5d9b372023-11-08T09:33:25ZExon skipping induces uniform dystrophin rescue with dose-dependent restoration of serum miRNA biomarkers and muscle biophysical propertiesJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:ef05285d-bc6a-4f34-9683-5b01ad5d9b37EnglishSymplectic ElementsCell Press2022Chwalenia, KOieni, JZemła, JLekka, MAhlskog, NCoenen-Stass, AMLMcClorey, GWood, MJALomonosova, YRoberts, TC<p>Therapies that restore dystrophin expression are presumed to correct Duchenne muscular dystrophy (DMD), with antisense-mediated exon skipping being the leading approach. Here we aimed to determine whether exon skipping using a peptide-phosphorodiamidate morpholino oligonucleotide (PPMO) conjugate results in dose-dependent restoration of uniform dystrophin localization, together with correction of putative DMD serum and muscle biomarkers. Dystrophin-deficient&nbsp;<em>mdx</em>&nbsp;mice were treated with a PPMO (Pip9b2-PMO) designed to induce&nbsp;<em>Dmd</em>&nbsp;exon 23 skipping at single, ascending intravenous doses (3, 6, or 12&nbsp;mg/kg) and sacrificed 2&nbsp;weeks later. Dose-dependent exon skipping and dystrophin protein restoration were observed, with dystrophin uniformly distributed at the sarcolemma of corrected myofibers at all doses. Serum microRNA biomarkers (i.e., miR-1a-3p, miR-133a-3p, miR-206-3p, miR-483-3p) and creatinine kinase levels were restored toward wild-type levels after treatment in a dose-dependent manner. All biomarkers were strongly anti-correlated with both exon skipping level and dystrophin expression. Dystrophin rescue was also strongly positively correlated with muscle stiffness (i.e., Young&rsquo;s modulus) as determined by atomic force microscopy (AFM) nanoindentation assay. These data demonstrate that PPMO-mediated exon skipping generates myofibers with uniform dystrophin expression and that both serum microRNA biomarkers and muscle AFM have potential utility as pharmacodynamic biomarkers of dystrophin restoration therapy in DMD.</p>
spellingShingle Chwalenia, K
Oieni, J
Zemła, J
Lekka, M
Ahlskog, N
Coenen-Stass, AML
McClorey, G
Wood, MJA
Lomonosova, Y
Roberts, TC
Exon skipping induces uniform dystrophin rescue with dose-dependent restoration of serum miRNA biomarkers and muscle biophysical properties
title Exon skipping induces uniform dystrophin rescue with dose-dependent restoration of serum miRNA biomarkers and muscle biophysical properties
title_full Exon skipping induces uniform dystrophin rescue with dose-dependent restoration of serum miRNA biomarkers and muscle biophysical properties
title_fullStr Exon skipping induces uniform dystrophin rescue with dose-dependent restoration of serum miRNA biomarkers and muscle biophysical properties
title_full_unstemmed Exon skipping induces uniform dystrophin rescue with dose-dependent restoration of serum miRNA biomarkers and muscle biophysical properties
title_short Exon skipping induces uniform dystrophin rescue with dose-dependent restoration of serum miRNA biomarkers and muscle biophysical properties
title_sort exon skipping induces uniform dystrophin rescue with dose dependent restoration of serum mirna biomarkers and muscle biophysical properties
work_keys_str_mv AT chwaleniak exonskippinginducesuniformdystrophinrescuewithdosedependentrestorationofserummirnabiomarkersandmusclebiophysicalproperties
AT oienij exonskippinginducesuniformdystrophinrescuewithdosedependentrestorationofserummirnabiomarkersandmusclebiophysicalproperties
AT zemłaj exonskippinginducesuniformdystrophinrescuewithdosedependentrestorationofserummirnabiomarkersandmusclebiophysicalproperties
AT lekkam exonskippinginducesuniformdystrophinrescuewithdosedependentrestorationofserummirnabiomarkersandmusclebiophysicalproperties
AT ahlskogn exonskippinginducesuniformdystrophinrescuewithdosedependentrestorationofserummirnabiomarkersandmusclebiophysicalproperties
AT coenenstassaml exonskippinginducesuniformdystrophinrescuewithdosedependentrestorationofserummirnabiomarkersandmusclebiophysicalproperties
AT mccloreyg exonskippinginducesuniformdystrophinrescuewithdosedependentrestorationofserummirnabiomarkersandmusclebiophysicalproperties
AT woodmja exonskippinginducesuniformdystrophinrescuewithdosedependentrestorationofserummirnabiomarkersandmusclebiophysicalproperties
AT lomonosovay exonskippinginducesuniformdystrophinrescuewithdosedependentrestorationofserummirnabiomarkersandmusclebiophysicalproperties
AT robertstc exonskippinginducesuniformdystrophinrescuewithdosedependentrestorationofserummirnabiomarkersandmusclebiophysicalproperties